Successfully Completed Pharmaceutical Water Systems Seminar by Dr. Teri C. Soli - NetZealous

NetZealous Announces Ongoing Seminar on The Topic, The A to Z's of Troubleshooting of Pharmaceutical Water Systems in Zurich, Switzerland. Dr. Teri C. Soli, President of Soli Pharma Solutions, Inc. will be the speaker at this seminar. This course is intended to equip participants an understanding of the centrality of biofilm to water systems.

This course has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

Fremont, CA: NetZealous, a leading provider of regulatory compliance trainings for a wide range of regulated industries, has begun a two-day seminar at Hilton Zurich Airport, Zurich on October 22. It will conclude on the next day. The topic of this highly interactive seminar is “The A to Z's of Microbial Control, Monitoring, Validation and Troubleshooting of Pharmaceutical Water Systems”. 

About the Seminar:

In this microbiology-focused education about all aspects of water systems, the speaker, Dr. Soli will offer knowledge of the proper design, validation, operation, monitoring, maintenance, troubleshooting, and excursion investigations of a high purity water system.

Lack of this understanding can result in costly system downtime or even product recalls. This interesting and interactive session will give participants insights into what actually lies behind some common water system designs and will bust a few myths about the same.

Pharmaceutical biofilms, especially those in water systems, thrive on fear and hype. No long term biofilm control can be achieved using a one-size-fits-all set of rules for design and operation. Biofilm can be controlled only when it is fully grasped. This is all the more important because each water system is unique. Water systems professionals need to get to the root of biofilm grows into their system, which, obviously, would be quite different from any other system.

The learning imparted at this course will is translatable to any system, with the result that uneventful microbial control can be achieved. This is the foundation to effective operation and design. The costs of failure far outweigh the educational costs that could have prevented it.

About the Speaker:

T.C. Soli is a Ph.D. Microbiologist and President of Soli Pharma Solutions, Inc. (www.solipharmasol.com), and since becoming a full time consultant, has served consumer products and FDA-regulated industries with training and troubleshooting expertise.

He is currently serving in his third five-year term on USP Expert Committees responsible for Pharmaceutical Waters through which he authored the complete rewrite of USP Chapter 1231, which many consider to be USP's "pharmaceutical water bible".

This is part of a series of seminars from NetZealous in which the highly respected Dr. Soli has been taking part. The series of seminars, which started in Singapore, also saw him flying to Dhaka, and then to Zurich to share his comprehensive knowledge of water systems with participants from these widely diffuse geographies.

Dr. Soli is upbeat about the response his seminars have been generating in these venues. At all these locations, the response was highly enthusiastic and overwhelmingly responsive. Dr. Soli too, has been fired up by the response his presentations have been getting from participants. He looks forward to being part of more such seminars from NetZealous.

                                           

About NetZealous:

NetZealous is a Fremont, CA-registered organization. GlobalCompliancePanel (http://www.globalcompliancepanel.com/) is NetZealous’ flagship brand. It is a source for a wide range of professional trainings, compliance trainings and consulting for the regulated industries. NetZealous offers a broad range of high quality regulatory and compliance-related services relating to medical devices, pharmaceutical, FDA, clinical trials, laboratory compliance, biologicals, drugs, food and biotechnology.

NetZealous has many well-known names among its clients. These include Bristol-Myers Squibb, Roche, Merck, Baxter, Johnson and Johnson, Pfizer, Abbot, Boehringer Ingelheim, Bayer, Molina Healthcare, Pfizer, Alcatel-Lucent, American Express, Medtronic, Lonza, Emerson Hospital, GlaxoSmithKline, Novartis and many more.

Media Contact:

Call: 1-800-447-9407;

Visit: http://www.netzealous.com/

Want to avoid penalties and ignominy? Ensure HIPAA compliance!

If you are a Business Associate or a Covered Entity or a healthcare organization that hires either or both of these; it is time to roll up your sleeves. Inspectors from the Office of Health and Human Services (HHS) could knock your door at any time to carry out HIPAA inspections. If you are not in compliance in even a single aspect, it could open a can of worms.

Heightened vigilance from HHS

Of late, the HHS has stepped up inspections and audits like no one’s business, looking out constantly for even the smallest violation of HIPAA Privacy Security. It is especially after Business Associates and Covered Entities. Seen from the HHS’ viewpoint; its stance is unexceptionable: Statistics show that Business Associates or Covered Entities account for a hefty share of the pie, being responsible for two thirds of the data breaches.

Since these two are readily and easily identifiable sources of HIPAA Privacy Security violations; it is but natural for the HHS to target these. And the procedure for nailing the offender? All that is given is a thirty-day notice period to rectify the fallout of the error. If the prescribed steps are not implemented in full and in good faith, the offender is labelled to have done these breaches accompanied by the legal phrase, mens rea, meaning a guilty mind. This forms the basis for arraignment, leading to a decision on the nature and quantity of punishment.

Means of avoiding hefty penalties

Why should organizations avoid being lax in enforcing HIPAA Privacy Security? It is because the facts are there to see: In 2014, HIPAA settlements amounted to millions of dollars in penalties and fines, the most notorious and publicized case being that of New York and Presbyterian Hospital (NYP), which was ordered to cough up nearly $ 5 million to the Office of Civil Rights (OCR).

Shouldn’t this serve as a warning to healthcare organizations and Business Associates and Covered Entities to spruce up their security? Yes, and the ways by which they can do this is through sheer diligence. Diligence of the holistic and comprehensive type, that is.

Get to the root of the problem

Typically, HIPAA Privacy Security should be aimed at locating the possible sources through which data breaches can happen. And then, the entity has to ensure that these are zeroed in on and insulated from possible leaks. Unencrypted data, human error, errors resulting from data stored in devices, and most importantly, from Business Associates –all these need to be secured, if the organization has to ensure HIPAA Privacy Security.

For more information click here: http://www.globalcompliancepanel.com/